The Financial Times (London) offers this headline today, "Pfizer gets $800m boost for Lipitor". If you want to read the entire story you will have to register with that news source. That really isn't necessary because I can tell you in just a few words what it is all about. From a financial perspective, Pfizer stands to generate huge sums of money by selling their Lipitor to children.
There's little to no evidence that cholesterol is harmful, and even less proof that statin drugs are beneficial in any way. In fact, there is plenty of evidence that statins are extremely harmful.
Why, then, is there a push to expand the use of the drug - especially to children? Three guesses. The first two don't count.
The deed is being perpetrated in the EU but it won't be long before it's available in the United States.
Tuesday, July 12, 2011
More drugs for kids!
See this Amp at http://on.ft.com/px3Mp3
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment